Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -352.19% is 56% below its 5-year average of -225.23%, near the high end of its 5-year range (-2468.61%–-70.94%).
As of the fiscal period ended Tuesday, June 30, 2026. 73.47% above its 12-month average of -1327.73%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q3 FY2026 (2026-06-30): -352.19%.
RETURN ON INVESTED CAPITAL (ROIC)
-352.19%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-1327.73%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-736.71%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-225.23%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-297.65%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+73.47%
CURRENT VS 3Y AVG
+52.19%
CURRENT VS 5Y AVG
-56.37%
CURRENT VS 10Y AVG
-18.33%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-888.06%
vs the sector median at left
Outlook Therapeutics, Inc.
Market Cap
$107.00M
Return on Invested Capital (ROIC)
-352.19%
TTM Avg
-1327.73%
3Y Avg
-736.71%
5Y Avg
-225.23%
Market Cap
$106.93M
Return on Invested Capital (ROIC)
-73.94%
TTM Avg
-76.71%
3Y Avg
-67.16%
5Y Avg
-152.71%
Market Cap
$106.83M
Return on Invested Capital (ROIC)
-34.77%
TTM Avg
-10.04%
3Y Avg
-11.68%
5Y Avg
-11.21%
Market Cap
$106.16M
Return on Invested Capital (ROIC)
-101.30%
TTM Avg
-45.83%
3Y Avg
-127.78%
5Y Avg
-123.84%
Market Cap
$105.70M
Return on Invested Capital (ROIC)
-92.16%
TTM Avg
-430.04%
3Y Avg
-259.02%
5Y Avg
-188.28%
Market Cap
$108.43M
Return on Invested Capital (ROIC)
-6.84%
TTM Avg
-23.14%
3Y Avg
-32.81%
5Y Avg
-31.36%
Market Cap
$109.20M
Return on Invested Capital (ROIC)
-97.99%
TTM Avg
-45.11%
3Y Avg
-60.38%
5Y Avg
-60.38%
Market Cap
$104.47M
Return on Invested Capital (ROIC)
41.64%
TTM Avg
-39.48%
3Y Avg
-25.23%
5Y Avg
-17.21%
Market Cap
$109.79M
Return on Invested Capital (ROIC)
-223.06%
TTM Avg
-221.51%
3Y Avg
-125.15%
5Y Avg
-99.68%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | $107.00M | -352.19% | -1327.73% | -736.71% | -225.23% |
| Vivani Medical, Inc. (VANI)vs › | $106.93M | -73.94% | -76.71% | -67.16% | -152.71% |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $106.83M | -34.77% | -10.04% | -11.68% | -11.21% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $106.16M | -101.30% | -45.83% | -127.78% | -123.84% |
| Immunic, Inc. (IMUX)vs › | $105.70M | -92.16% | -430.04% | -259.02% | -188.28% |
| Apyx Medical Corporation (APYX)vs › | $108.43M | -6.84% | -23.14% | -32.81% | -31.36% |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $109.20M | -97.99% | -45.11% | -60.38% | -60.38% |
| Definitive Healthcare Corp. (DH)vs › | $104.47M | 41.64% | -39.48% | -25.23% | -17.21% |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $109.79M | -223.06% | -221.51% | -125.15% | -99.68% |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.18M | -47.75% | -127.40% | -174.63% | -174.63% |
ROIC
-352.2%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -352.19% |
| 2025-12-31 | -1008.75% |
| 2025-09-30 | -2468.61% |
| 2025-06-30 | -1481.36% |
| 2025-03-31 | -1222.29% |
| 2024-09-30 | -456.43% |
| 2024-06-30 | -165.77% |
| 2024-03-31 | -120.46% |
| 2023-12-31 | -389.56% |
| 2023-09-30 | -251.55% |
| 2023-06-30 | -186.85% |
| 2023-03-31 | -126.51% |
| 2022-12-31 | -137.82% |
| 2022-09-30 | -319.95% |
| 2022-06-30 | -204.20% |
| 2022-03-31 | -96.47% |
| 2021-12-31 | -70.94% |
| 2021-09-30 | -304.93% |
| 2021-06-30 | -194.83% |
| 2021-03-31 | -147.41% |
| 2020-12-31 | -5036.62% |
| 2020-09-30 | -470.29% |
| 2020-06-30 | -240.02% |
| 2019-12-31 | -3259.43% |
| 2019-09-30 | -443.62% |
| 2019-06-30 | -168.67% |
| 2019-03-31 | -1526.70% |
| 2018-12-31 | -749.27% |
| 2018-09-30 | -365.99% |
| 2018-06-30 | -102.44% |
| 2018-03-31 | -150.48% |
| 2017-12-31 | -116.43% |
| 2016-09-30 | -611.22% |
| 2016-06-30 | -381.09% |
| 2015-12-31 | -659.08% |
| 2015-09-30 | -733.23% |
